FTLP13

Across TCGA pan-cancer cohorts, FTLP13 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated FTLP13 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher FTLP13 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FTLP13 expression acts as an unfavorable survival marker, although some lineages such as STAD and SKCM show a favorable association.

COAD, THYM, and THCA are the cancer types where FTLP13 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	III,IV	0.140	0.783	.001	45	view →
THYM	DFS	Tertile	II,III,IV	0.145	0.873	<.001	36	view →
THCA	OS	Tertile	III,IV	0.585	0.887	.006	27	view →
PAAD	DFS	Tertile	II,III,IV	0.160	0.437	.036	18	view →
STAD	OS	Tertile	IV	0.729	0.246	.016	18	view →
LUAD	OS	Tertile	All	0.368	0.701	.007	18	view →
SARC	OS	Tertile	All	0.165	0.523	.008	12	view →
SKCM	DFS	Tertile	All	0.871	0.717	.017	9	view →
KIRP	DFS	Tertile	III,IV	1.000	0.311	.048	3	view →
LGG	OS	Tertile	All	1.000	0.495	.042	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

FTLP13–COAD (OS)

Open the COAD breakdown →